The FDA is about two years away from approving psilocybin and MDMA for treating PTSD, but most of the general public has been in the dark. Read More
The following search results are from Investing Daily's public research only. Please Log In to search your premium services.
Results
The stock market has rebounded lately due to a confluence of unexpectedly good news, but bullish factors could quickly sour this summer. Read More
New bullish trends are emerging in the semiconductor sector. Here's the best way to capitalize on them. Read More
Pundits are divided into two camps, one arguing we’re in a recession and the other claiming it's too soon to say. Does it matter who's right? Read More
While the Russo-Ukrainian War is being blamed for inflation, prices were rising even before the invasion. This time, things are different. Read More
Markets currently expect the Federal Reserve to get less hawkish in the autumn, a factor that’s been driving stocks higher. Read More
Water stocks have performed well in the past, and given the world's freshwater dilemma, promise good returns in the future. Read More
The latest economic data indicate elevated inflation and slowing economic growth, and yet equities have been posting sharp gains. What gives? Read More
Consumers are sending some very loud signals to the stock market, and here is one way you can profit from it. Read More
We’ve suffered a brutal first half of 2022, but it seems the bear market has bottomed, and Wall Street's biggest fears haven't materialized. Read More
Stock Talk Results
No Comments Found